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Apparent successful mesothelial cell transplantation hampered
by peritoneal activation.
Background. Mesothelial cell transplantation has been sug-
gested to improve mesothelial repair after surgery, recurrent
peritonitis and peritoneal dialysis.
Methods. In this study we evaluated mesothelial cell trans-
plantation during the resolution phase of experimentally
thioglycollate-induced peritonitis in rats. To this end 4 × 106
DiO-labeled autologous mesothelial cells were transplanted
1 week after peritonitis induction. Peritoneal inflammation and
permeability characteristics were evaluated after another week.
Results. Mesothelial cell transplantation after peritonitis re-
sulted in incorporation of these cells in the parietal mesothelial
lining, leading to an acute transient submesothelial thickening
which was not seen in transplanted animals without prior peri-
tonitis induction. Long-term functioning of these repopulated
mesothelial cells leaded to peritoneal activation as evidenced
by a ∼twofold increase in peritoneal lymphocytes (P < 0.01)
and omental mast cell counts (P < 0.05), accompanied by the
induction of inflammation markers monocyte chemoattractant
protein-1 (MCP-1) (P < 0.01) and hyaluronan (P < 0.01) in the
transplanted peritonitis group, but not in rats with peritonitis
without mesothelial cell transplantation or in control rats with-
out mesothelial cell transplantation (all four parameters P <
0.01). In addition, trapping of transplanted mesothelial cells
in the milky spots of omental tissue and lymphatic stomata of
the diaphragm both in control and thioglycollate rats seems to
increase microvascular permeability, reflected by apparent in-
creased diffusion rates of small solutes and proteins.
Conclusion. Altogether, our data underscore the importance
of controlling peritoneal (patho)physiology and function in
mesothelial transplantation protocols.
Mesothelial cells cover the entire peritoneal cavity and
orchestrate local inflammatory responses, regulate peri-
toneal microcirculation, and maintain a balance between
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fibrin deposition and degradation in the peritoneum [1].
The mesothelium has shown to be damaged upon peri-
tonitis, surgery, chronic inflammation, and peritoneal
dialysis. Under normal conditions, serosal healing is com-
pleted within 7 to 10 days [2]. The process of remesothe-
lialization and the origin of new mesothelial cells remain
controversial. New mesothelium is thought to be derived
from mature mesothelial cells, which detach from the
opposing peritoneal surface [3], migrate from the bor-
der of the injury [4], or originate from a free-floating
mesothelial cell/progenitor in serosal fluid [5]. In biop-
sies of long-term peritoneal dialysis patients denuded ar-
eas in the mesothelial monolayer have been described [6].
Serosal injury can lead to the formation of internal scars
or adhesions [7] as a consequence of an imbalance be-
tween fibrin degradation and formation by the mesothe-
lium. Mesothelial cell transplantation is aimed to improve
serosal repair.
Successful mesothelial cell transplantation has been re-
ported in various animal models and even in a clinical
study [8–11]. However, since in these studies only a single
parameter was studied (adhesion formation or ultrafil-
tration) this conclusion might be preliminary. We there-
fore performed experiments to further unravel the effects
of mesothelial cell transplantation during the resolution
phase of experimental thioglycollate-induced peritonitis.
Immunologic, morphologic, and functional parameters
were evaluated. In the present study we show that suc-
cessful mesothelial cell transplantation is accompanied
by prolongation of the inflammatory status of the peri-
toneum. Our findings indicate the importance of control
of peritoneal function and (patho)physiology upon ther-
apeutic transplantation of mesothelial cells.
METHODS
Experimental design
Experiment 1 used male 280 to 300 g Wistar rats (Har-
lan CPB, Zeist, The Netherlands) injected with 5 mL
thioglycollate intraperitoneally. One week later, 2 mL
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containing 4 × 106 DiO-labeled mesothelial cells (TM
group) or 2 mL saline (TS group) was injected intraperi-
toneally. As control groups rats were injected ip either
with DiO-labeled mesothelial cells (CM group) or saline
(CS group) without prior thioglycollate. One week af-
ter mesothelial cell transplantation or saline the animals
were sacrificed. A peritoneal wash was performed and
peritoneal wall and omentum were excised for morpho-
logic studies.
Experiment 2 was a parallel experiment in which a stan-
dard permeability analysis described by Zweers et al [12]
was performed for 4 hours using 3.86% glucose dialysis
fluid to test the permeability characteristics of the peri-
toneal microcirculation.
Experiment 3 was intended to study the immediate ef-
fects of mesothelial cell transplantation during the acute
phase of peritonitis. Mesothelial cells were transplanted
1 day after thioglycollate injection and animals were sac-
rificed 2 days later. In all three experiments, six rats per
group were included. The Animal Care Committee of the
Vrije Universiteit of Amsterdam approved all animal ex-
periments described.
Mesothelial cells
Primary peritoneal mesothelial cells were isolated by
enzymatic digestion of the parietal peritoneal walls of
adult rats and subsequently cultured as described [10,
11]. Confluent mesothelial cells (passage 4) were la-
beled with the lipophylic fluorescent tracer DiO (C18)
(Sigma-Aldrich Chemie BV., Zwijndrecht, The Nether-
lands) in a final concentration of 25 lg/mL at 37◦C
for 16 hours culture medium. DiO belongs to the
family of dialkylcarbocyanines, tracers that selectively
labels the plasma membranes and do not transfer
from labeled to unlabeled cells and have been used
in earlier transplantation protocols (see www.probes.
com/handbook/sections/1404.html). Labeling efficiency
was always >95%. The cells were washed thoroughly,
removed from the culture dish with 0.25% trypsin-
0.53 mmol/L ethylenediaminetetraacetic acid (EDTA)
(Gibco-BRL, Gaithersburg, MD, USA) and washed sev-
eral times with Hank’s balanced salt solution (HBSS)
prior to intraperitoneal injection. Control injections were
performed using the same volume (2 mL) HBSS.
Peritoneal effluent
Peritoneal leukocytes were collected from the peri-
toneal cavity by peritoneal wash with 10 mL HBSS
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−→
Fig. 1. Thioglycollate injection damages the mesothelial cell layer of the peritoneal membrane. Representative photographs of en face silver stained
parietal peritoneum of a control animal (A) and 1 week after a single injection with thioglycollate (B). The borders of the mesothelial cells as well
as the damaged mesothelial cells are stained black with silver. Representative light microscopic photographs of sectioned parietal peritoneum of
mesothelial cell transplanted rats with (D) and without (C) prior injection with thioglycollate. An overlay of light microscopic photograph and a
fluorescence photograph is given. Transplanted mesothelial cells were a-specifically trapped into the milky spots of the omentum (E). DiO-labeled
mesothelial cells in (D) and (E) are represented by black (D) or white (E) cells [magnification (A to D) 100×; (E) 50×].
(Gibco, BRL). Cells were counted and differentiated. In
peritoneal effluent monocyte chemoattractant protein-
1 (MCP-1) levels were determined by enzyme-linked
immunosorbent assay (ELISA) according to manufac-
turer’s instruction (PharMingen, San Diego, CA, USA).
Hyaluronan was determined in an ELISA-based assay es-
sentially according to Fosang et al [13]. Interleukin (IL)-
1b and IL-6 concentrations were determined by ELISA
using antibody pairs (NIBSC, South Mimms, UK), and
nitric oxide with Griess reagent.
Morphologic examination of the omentum
and peritoneum
The omentum was dissected and spread on a glass slide
for light microscopic examination. Since mast cells ac-
cumulate in the omentum upon peritoneal activation,
sections were stained with toluidin blue and the den-
sity of mast cells was counted as described [14]. Spec-
imens of peritoneal wall were frozen and sectioned at
8 lm and stained using Hoechst (10 lg/mL). Thickness
of submesothelial matrix layer was evaluated using a
scored eyepiece (10 measurements/animal) as described
[14]. Repopulation of transplanted mesothelial cells was
evaluated by fluorescence microscopy. Whole mount
preparations of peritoneal wall were en face stained by
conventional silver staining [11].
Statistical analysis
All data (presented as median and 25% to 75% in-
terquartile ranges) were analyzed using the nonparamet-
ric Mann-Whitney U test. Probability values <0.05 were
regarded as significant.
RESULTS
First, mesothelial cell damage by thioglycollate was
visualized. To this end, thioglycollate was injected in-
traperitoneally and parietal peritoneal wall of the treated
animals were stained with silver 1 week after the injec-
tion. As is shown in Figure 1A and B, thioglycollate fo-
cally damages the mesothelial monolayer in accordance
with earlier findings [11].
Mesothelial cells were injected in control animals (CM)
to evaluate homing of the mesothelial cells in animals
with an intact peritoneum. As we described previously
[11], no attachment of mesothelial cells was observed in
the parietal peritoneum (Fig. 1C). DiO-labeled mesothe-
lial cells were however observed in the milky spots of
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Table 1. Peritoneal inflammation and permeability parameters
Control Control (mesothelial Thioglycollate Thioglycollate (mesothelial
(saline) cell treatment) (saline) cell treatment)
Experiment 1
Peritoneal lavage
Lymphocytes % 0.5 (0.0-0.5) 1.5 (1.0-2.5) 3.0 (2.4-3.6) 6.0 (5.8-7.0)a,c
MCP-1 pg/mL <500 (all rats) <500 (one rat 820) <500 (all rats) 925 (770-1110)a,b,c
Hyaluronan ng/mL 87 (84-112) 191 (71-220) 136 (135-151) 270 (234-316)a,c
Omental mast cells per mm2 20 (17-21) 20 (18-25) 24 (16-36) 47 (39-51)a,d,e
Experiment 2
Dialysate over plasma ratio
Glucose 4.61 (3.88-5.19) 2.64 (2.20-3.71) 2.83 (2.61-3.76) 2.95 (2.87-3.49)
Urea 0.74 (0.72-0.79) 0.79 (0.75-0.83) 0.74 (0.70-0.75) 0.74 (0.74-0.80)
Creatinine 0.41 (0.38-0.42)f,g 0.53 (0.47-0.56) 0.56 (0.54-0.57) 0.53 (0.50-0.54)
Albumin ×10E-3 5.99 (4.80-7.54) 11.05 (7.91-14.04) 6.91 (6.02-7.06) 8.11 (6.25–11.77)
IgG ×10E-3 1.90 (1.51-2.11)h 3.07 (2.59-4.43) 1.94 (1.39-2.30) 2.76 (2.68–3.39)
aTM versus CS P < 0.01; bTM versus CM P < 0.01; cTM versus TS: P < 0.01; dTM versus CM P < 0.02; eTM versus TS P < 0.05; fCS versus TS P < 0.01; gCS versus
TM P < 0.01; hCS versus CM P < 0.05.
the omentum (Fig. 1E) and in the lymphatics of the di-
aphragm (not shown). This aspecific mesothelial cell trap-
ping yielded no inflammatory response (CM versus CS)
(Table 1, experiment 1); however, permeability parame-
ters were apparently influenced (CM versus CS) (Table 1,
experiment 2). Although only D/P ratio of IgG reached
the P < 0.05 level, data suggest increased transport of
small solutes and proteins.
Three days after thioglycollate (experiment 3) an early
peritoneal inflammatory response was found, character-
ized by two- to fourfold increases in macrophages (me-
dian values TS 18 × 106 versus CS 9 × 106) (P < 0.05) and
MCP-1 (TS 2.6 versus CS 0.7 ng/mL) (P < 0.03), accom-
panied by 12-fold induction of hyaluronan (TS 865 versus
CS 71 ng/mL) (P < 0.02). Mesothelial cell transplantation
did not modulate this inflammatory response, although a
significant increased thickness of the submesothelial ma-
trix layer in the TM group compared to all three other
groups was found (median values TM 36 lm versus TS
21 lm, CM 27 lm, and CS 23 lm) (P < 0.05). The acute
response in the TS group is almost completely solved in
2 weeks. No significant differences are found anymore
between the TS group and the CS group (Table 1, exper-
iment 1). However, D/P ratio of creatinine was signifi-
cantly increased, suggesting increased peritoneal transfer
of small solutes upon thioglycollate. This is also suggested
by apparent decreased D/P glucose and increased D/P al-
bumin, although not reaching P < 0.05 level.
When mesothelial cells are injected 1 week after thio-
glycollate injection, they were found to be incorporated
into the parietal peritoneum (Fig. 1D), leading to a pro-
longed inflammatory condition of the peritoneum. Al-
though a similar cell number is found among the four
experimental groups (not shown), the percentage of lym-
phocytes in the TM group is significantly higher than in
the TS and CS group (Table 1). In addition, the TM group
is the only group in which MCP-1 is detectable, 930 (770
to 1110) pg/mL. Hyaluronan in the peritoneal effluent of
animals in the TM group was significantly increased com-
pared to the TS and the CS group. In addition, the number
of omental mast cells was significantly increased in the
TM group versus all other groups. IL-1b , IL-6, and nitric
oxide levels were below detection limits in the peritoneal
wash fluids of all animals. Submesothelial thickness was
not different among the groups.
As was observed in the CM and the TS groups,
transplantation with mesothelial cells resulted in appar-
ent increased peritoneal microcirculation permeability.
Again, only significance was reached for D/P creati-
nine (P < 0.01). However, since the same tendencies
(increased small solute and macromolecular transport)
were observed in both transplanted groups and in both
thioglycollate groups, our data are quite suggestive for
increased peritoneal permeability secondary to mesothe-
lial cell transplantation or thioglycollate, however, both
events are not additive.
DISCUSSION
In this communication we show that during the
resolution phase of experimental peritonitis mesothe-
lial cell transplantation and subsequent incorpora-
tion/functioning of those cells in the mesothelial lining,
results in a prolonged inflammatory status of the peri-
toneum. This finding raises fundamental questions on
the applicability of mesothelial cell transplantation. We
and others have shown that mesothelial cell transplanta-
tion is feasible after mesothelial cell damage caused by
acute inflammation, chronic inflammation, and surgery
in both animal models and patients on peritoneal dialysis
[8–11]. These promising results suggested that mesothe-
lial cell transplantation might offer an excellent approach
to preserve the integrity and improve the performance
of the peritoneal membrane. Moreover, mesothelial cells
have been genetically modified to express different types
of recombinant proteins (i.e., intracellular, secreted, and
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membrane-bound) in vivo [15–17], indicating that genet-
ically modified mesothelial cells can be used to deliver
potentially therapeutic recombinant proteins. Our cur-
rent results however suggest that some care should be
taken by interpretation of the previous mentioned re-
ports. First, mesothelial cell transplantation and subse-
quent functioning in the mesothelial lining (TM versus
TS) resulted in a more prolonged inflammatory status of
the peritoneal cavity evidenced by increased inflamma-
tory mediators and cell numbers. Second, the trapping of
mesothelial cells to omental tissue and diaphragm, which
are normal drainage routes, seems to result in apparent
greater diffusion rates of serum proteins and higher trans-
fer of small solutes in both the control mesothelial cell
group as well as in the TM group compared to untrans-
planted animals, although statistical significance was only
reached for some of the parameters. Finally, mesothe-
lial cell transplantations using a different time frame in
the acute inflammatory phase (1 day after thioglycol-
late, followed by sacrifice 2 days later) (experiment 3)
resulted in a significant increased thickness of the subme-
sothelial matrix layer, most likely due to edema forma-
tion somehow related to the repopulation of transplanted
mesothelial cells into the mesothelium. These three ob-
servations suggest an activation of the peritoneal cavity
upon incorporation of the transplanted mesothelial cells
to the denuded areas (acute phase, peritoneal edema, and
long-term, increased inflammation) or the aspecific trap-
ping of mesothelial cells to the drainage routes in omen-
tum and diaphragma (apparent increased peritoneal
transport).
The absence of IL-1b , IL-6, and nitric oxide in the peri-
toneal dwells of all rats including those of the TM group
indicates that the prolonged activation of the peritoneum
upon mesothelial cell transplantation is not simply due to
an ongoing acute inflammatory reaction, rather to a long-
term stimulation by the settled mesothelial cells. The ab-
sence of acute proinflammatory mediators nicely fits with
the lack of increased neutrophil or monocyte numbers in
the peritoneal dwells, the increased number of lympho-
cytes in the TM group perfectly fits into the picture of a
chronic inflammatory response.
At present we do not know whether this long-term
peritoneal activation is specific for mesothelial cells or re-
lated to intraperitoneal cell transplantations in general.
Based on preliminary data using epithelial colon carci-
noma CC531 cell transplantations and data in literature
on intraperitoneal transplantation of pancreatic islands
[17] we speculate that a chronic inflammatory state of
the peritoneum is more related to cell adherence and re-
tention in general rather than a mesothelial cell–specific
phenomenon. This even makes the message of our report
of more importance. We feel that our findings might be
of clinical importance since high peritoneal transport as
well as high dialysate hyaluronan levels are both associ-
ated with increased morbidity and mortality in peritoneal
dialysis patients [18, 19].
Can this peritoneal activation by transplanted
mesothelial cells be prevented somehow? We cannot ex-
clude that the culturing conditions used by us and all
other investigators in this field activated the mesothe-
lial cells to some extent and might have contributed to
the peritoneal activation. Transplantation of mesothelial
cells has recently been performed using mesothelial cells
preembedded in a collagen matrix [20]. This approach
might be relevant for long-term survival of the grafted
mesothelial cells. However, in order to increase mesothe-
lial repair, transplanted mesothelial cells have to be incor-
porated onto denuded areas of the peritoneal membrane,
which does not occur when embedded in collagen matri-
ces. Exploitation of mesothelial progenitor cells may offer
a challenging therapeutic approach for both surgery and
peritoneal dialysis [21]. Numerous studies suggest that a
mesothelial cell progenitor exists (reviewed in [22]). In-
deed, in a pilot study, in which mice were denuded of their
mesothelial cells and engrafted with an enriched popula-
tion of c-Kit+, Sca+, Lin− bone marrow cells (mesenchy-
mal stem cells) of donor mice, we found evidence pointing
in the direction of a possible mesothelial progenitor
cell in the bone marrow. These promising experiments
however, need further study and will be communicated
separately.
CONCLUSION
Mesothelial cell transplantation after thioglycollate in-
jection activates the peritoneal cavity, which results in
changes in the peritoneal physiology. These results em-
phasize proper control of peritoneal (patho)physiology
and function in therapeutic transplantation of cultured
mesothelial cells.
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